Physicians' knowledge of future vascular disease in women with preeclampsia

Hypertension in Pregnancy

Volumn 31, Issue 1, 2012, Pages 50-58

  Young, Brett ^a   Hacker, Michele R ^b   Rana, Sarosh ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Ischemic heart disease; Preeclampsia; Primary prevention; Stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; FEMALE; GENERAL PRACTITIONER; HEALTH HAZARD; HUMAN; ISCHEMIC HEART DISEASE; KNOWLEDGE; LIFE EXPECTANCY; PATIENT COUNSELING; PHYSICIAN; PREECLAMPSIA; RISK REDUCTION; STROKE; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; FEMALE; GYNECOLOGY; HUMANS; INTERNAL MEDICINE; OBSTETRICS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84455212319     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2010.544955     Document Type: Article

References (17)

1. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99(1):159-167.
2. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005; 16(2):206-215. (Pubitemid 40314413)
3. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323(7323):1213-1217.
4. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366(9499):1797-1803. (Pubitemid 41642644)
5. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357(9273):2002-2006. (Pubitemid 32592386)
6. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359(8):800-809.
7. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672-683. (Pubitemid 38364626)
8. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355(10):992-1005. (Pubitemid 44343543)
9. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649-658. (Pubitemid 36278583)
10. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161(5):1200-1204. (Pubitemid 20007682)
11. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115(11):1481-1501. (Pubitemid 46648385)
12. Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008; 2(4):249-259.
13. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009; 114(5):961-970.
14. Lewis BG, Halm EA, Marcus SM, Korenstein D, Federman AD. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol 2008; 111(4):945-952. (Pubitemid 351482628)
15. Saade G. Pregnancy as a window to future health. Obstet Gynecol 2009; 114(5):958-959.
16. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111(4):499-510. (Pubitemid 40204436)
17. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 2008; 6(8):1-29.